S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

EVOK Evoke Pharma Inc

4.36

-0.03 (-0.68%)

After Hours

Last Updated: 15:51:03

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Evoke Pharma Charts.

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Evoke Pharma Charts.

Evoke Pharma Inc News

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 22 November 2024 (5 days ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Thursday 7 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 6 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 28 October 2024 (1 month ago) • Edgar (US Regulatory)

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
Monday 28 October 2024 (1 month ago) • GlobeNewswire Inc.

Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
Wednesday 23 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 22 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 22 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 22 October 2024 (1 month ago) • Edgar (US Regulatory)

More Evoke Pharma Inc News Articles

Pender Growth (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions